bbT369, a dual-targeted (CD79a/CD20) and CBLB gene edited autologous CAR T for non-Hodgkin lymphoma, showed edit-driven enhanced T cell activity in multiple preclinical models RESET, a novel TCR ...

Yatiri Bio Inc. today announced it has received a grant from the Gates Foundation to launch a one-year project, Proteomics Interoperability, aimed at improving how large-scale proteomics data can be ...

Nabla Bio has entered a new multi-year research collaboration with Takeda to advance AI-driven design of protein therapeutics ...

SAN DIEGO--(BUSINESS WIRE)--Rejuvenate Bio, today announced new preclinical efficacy data for RJB-0402, a gene therapy targeting key disease-mediating pathways. RJB-0402 demonstrated efficacy in a ...

PHILADELPHIA--(BUSINESS WIRE)--Latus Bio, Inc. (Latus), a biotechnology company pioneering advances in AAV gene therapy, is pleased to announce data presentations in support of its preclinical drug ...

Bio Protocol raises $6.9M in seed funding led by Arthur Hayes’ Maelstrom Fund to expand its decentralised science initiatives.

Cabaletta Bio (CABA) has attracted fresh attention after presenting early data from its RESET-PV clinical trial at the ESGCT Congress. The company reported that its CAR T cell therapy, rese-cel, ...

Researchers from Universiti Tun Hussein Onn Malaysia and Chettinad Institute of Technology developed a Golden Eagle-Assisted ...

Want smarter insights in your inbox? Sign up for our weekly newsletters to get only what matters to enterprise AI, data, and security leaders. Subscribe Now Data mesh is a hot topic in the data and ...